47 Percent Of New Drugs In The United States Come With Price Tag Of $150,000 Or More
As a result of the blatant profiteering described in this news story, total prescription drug spending in the United States exceeded a whopping half a trillion dollars in 2020. Globally, spending on drugs is expected to reach $1.8 trillion annually by 2026. This includes spending on the highly profitable COVID-19 vaccines, which is expected to grow substantially in the coming years.
Anybody who understands the pharma industry’s business model will not be surprised by this profit-driven mentality. In reality, the pharma industry is not a health industry at all, it is an investment business. While pretending to deliver health to the world, its entire existence is based on promoting diseases as multibillion dollar markets for patented drugs.
Moreover, the elimination of diseases, the very goal the pharma industry claims to be serving, is actually being fought against vigorously by it. The reason for this is obvious: the eradication of diseases would destroy the global drug market upon which the pharma industry is based, as well as also destroying the drug companies themselves. This explains why most prescription drugs only treat symptoms rather than targeting the primary cause of diseases.
To learn the facts about the pharma industry that the mainstream media isn’t sharing with you, see the ‘Pharma Facts’ feature page on our website.
